#ASCO2017 Prognosis of leptomeningeal metastases from melanoma: A case series of 28 patients. Leia mais »
#ASCO2017 Cambridge Brain Mets Trial 1 (CamBMT1): A proof of principle study of afatinib penetration into cerebral metastases (mets) for patients (pts) undergoing neurosurgical resection, combined with low-dose, targeted radiotherapy (RT)—Phase 1b results. Leia mais »
